Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Biochemistry
2018 May 08;5718:2733-2743. doi: 10.1021/acs.biochem.8b00292.
Show Gene links
Show Anatomy links
Synthetic Analogues of the Snail Toxin 6-Bromo-2-mercaptotryptamine Dimer (BrMT) Reveal That Lipid Bilayer Perturbation Does Not Underlie Its Modulation of Voltage-Gated Potassium Channels.
Dockendorff C
,
Gandhi DM
,
Kimball IH
,
Eum KS
,
Rusinova R
,
Ingólfsson HI
,
Kapoor R
,
Peyear T
,
Dodge MW
,
Martin SF
,
Aldrich RW
,
Andersen OS
,
Sack JT
.
???displayArticle.abstract???
Drugs do not act solely by canonical ligand-receptor binding interactions. Amphiphilic drugs partition into membranes, thereby perturbing bulk lipid bilayer properties and possibly altering the function of membrane proteins. Distinguishing membrane perturbation from more direct protein-ligand interactions is an ongoing challenge in chemical biology. Herein, we present one strategy for doing so, using dimeric 6-bromo-2-mercaptotryptamine (BrMT) and synthetic analogues. BrMT is a chemically unstable marine snail toxin that has unique effects on voltage-gated K+ channel proteins, making it an attractive medicinal chemistry lead. BrMT is amphiphilic and perturbs lipid bilayers, raising the question of whether its action against K+ channels is merely a manifestation of membrane perturbation. To determine whether medicinal chemistry approaches to improve BrMT might be viable, we synthesized BrMT and 11 analogues and determined their activities in parallel assays measuring K+ channel activity and lipid bilayer properties. Structure-activity relationships were determined for modulation of the Kv1.4 channel, bilayer partitioning, and bilayer perturbation. Neither membrane partitioning nor bilayer perturbation correlates with K+ channel modulation. We conclude that BrMT's membrane interactions are not critical for its inhibition of Kv1.4 activation. Further, we found that alkyl or ether linkages can replace the chemically labile disulfide bond in the BrMT pharmacophore, and we identified additional regions of the scaffold that are amenable to chemical modification. Our work demonstrates a strategy for determining if drugs act by specific interactions or bilayer-dependent mechanisms, and chemically stable modulators of Kv1 channels are reported.
Altenbach,
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
2008, Pubmed
Altenbach,
Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands.
2008,
Pubmed
Andersen,
Perspectives on how to drug an ion channel.
2008,
Pubmed
Andersen,
Bilayer thickness and membrane protein function: an energetic perspective.
2007,
Pubmed
Baconguis,
X-ray structure of acid-sensing ion channel 1-snake toxin complex reveals open state of a Na(+)-selective channel.
2014,
Pubmed
Baconguis,
Structural plasticity and dynamic selectivity of acid-sensing ion channel-spider toxin complexes.
2012,
Pubmed
Bae,
Structural insights into the mechanism of activation of the TRPV1 channel by a membrane-bound tarantula toxin.
2016,
Pubmed
Bagal,
Ion channels as therapeutic targets: a drug discovery perspective.
2013,
Pubmed
Baran,
Total synthesis of (+/-)-chartelline C.
2006,
Pubmed
Browning,
Amphipathic amines affect membrane excitability in paramecium: role for bilayer couple.
1976,
Pubmed
Bruno,
Docosahexaenoic acid alters bilayer elastic properties.
2007,
Pubmed
Börjesson,
Electrostatic tuning of cellular excitability.
2010,
Pubmed
,
Xenbase
Cao,
TRPV1 structures in distinct conformations reveal activation mechanisms.
2013,
Pubmed
Cobb,
Cell Cycle-dependent Changes in Localization and Phosphorylation of the Plasma Membrane Kv2.1 K+ Channel Impact Endoplasmic Reticulum Membrane Contact Sites in COS-1 Cells.
2015,
Pubmed
Dawson,
Structure of the acid-sensing ion channel 1 in complex with the gating modifier Psalmotoxin 1.
2012,
Pubmed
Du,
Potassium channels in peripheral pain pathways: expression, function and therapeutic potential.
2013,
Pubmed
Gao,
TRPV1 structures in nanodiscs reveal mechanisms of ligand and lipid action.
2016,
Pubmed
Gao,
Synthesis of the non-peptidic snail toxin 6-bromo-2-mercaptotryptamine dimer (BrMT)(2), its lower and higher thio homologs and their ability to modulate potassium ion channels.
2013,
Pubmed
,
Xenbase
Gingrich,
Pentobarbital produces activation and block of {alpha}1{beta}2{gamma}2S GABAA receptors in rapidly perfused whole cells and membrane patches: divergent results can be explained by pharmacokinetics.
2009,
Pubmed
Guo,
Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.
2005,
Pubmed
Gupta,
Tarantula toxins use common surfaces for interacting with Kv and ASIC ion channels.
2015,
Pubmed
,
Xenbase
Gutman,
International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels.
2005,
Pubmed
Heerklotz,
Titration calorimetry of surfactant-membrane partitioning and membrane solubilization.
2000,
Pubmed
Herold,
Clinical concentrations of chemically diverse general anesthetics minimally affect lipid bilayer properties.
2017,
Pubmed
Howery,
A designed inhibitor of a CLC antiporter blocks function through a unique binding mode.
2012,
Pubmed
Huang,
Characterization of voltage-gated sodium-channel blockers by electrical stimulation and fluorescence detection of membrane potential.
2006,
Pubmed
Hwang,
Genistein can modulate channel function by a phosphorylation-independent mechanism: importance of hydrophobic mismatch and bilayer mechanics.
2003,
Pubmed
Höllerer-Beitz,
Influence of detergents on the function of cloned potassium channels.
1998,
Pubmed
,
Xenbase
Ingólfsson,
Screening for small molecules' bilayer-modifying potential using a gramicidin-based fluorescence assay.
2010,
Pubmed
Ingólfsson,
Phytochemicals perturb membranes and promiscuously alter protein function.
2014,
Pubmed
Ingólfsson,
Gramicidin-based fluorescence assay; for determining small molecules potential for modifying lipid bilayer properties.
2010,
Pubmed
Kelley,
Characterization of a novel gastropod toxin (6-bromo-2-mercaptotryptamine) that inhibits shaker K channel activity.
2003,
Pubmed
,
Xenbase
Lee,
A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom.
2004,
Pubmed
Liao,
Structure of the TRPV1 ion channel determined by electron cryo-microscopy.
2013,
Pubmed
Lundbaek,
Membrane stiffness and channel function.
1996,
Pubmed
Lundbaek,
Regulation of sodium channel function by bilayer elasticity: the importance of hydrophobic coupling. Effects of Micelle-forming amphiphiles and cholesterol.
2004,
Pubmed
Lundbaek,
Amphiphile regulation of ion channel function by changes in the bilayer spring constant.
2010,
Pubmed
Lundbaek,
Capsaicin regulates voltage-dependent sodium channels by altering lipid bilayer elasticity.
2005,
Pubmed
Lundbaek,
Lipid bilayer regulation of membrane protein function: gramicidin channels as molecular force probes.
2010,
Pubmed
Manganas,
Identification of a trafficking determinant localized to the Kv1 potassium channel pore.
2001,
Pubmed
Manganas,
Subunit composition determines Kv1 potassium channel surface expression.
2000,
Pubmed
Martinac,
Mechanosensitive ion channels of E. coli activated by amphipaths.
1990,
Pubmed
Milescu,
Tarantula toxins interact with voltage sensors within lipid membranes.
2007,
Pubmed
,
Xenbase
Milescu,
Interactions between lipids and voltage sensor paddles detected with tarantula toxins.
2009,
Pubmed
Moore,
Direct spectroscopic studies of cation translocation by Torpedo acetylcholine receptor on a time scale of physiological relevance.
1980,
Pubmed
Morris,
Nav channel mechanosensitivity: activation and inactivation accelerate reversibly with stretch.
2007,
Pubmed
,
Xenbase
Nagy,
Kinetics and mechanisms of thiol-disulfide exchange covering direct substitution and thiol oxidation-mediated pathways.
2013,
Pubmed
Ottosson,
A drug pocket at the lipid bilayer-potassium channel interface.
2017,
Pubmed
Rasband,
Distinct potassium channels on pain-sensing neurons.
2001,
Pubmed
Rasmusson,
Inactivation of voltage-gated cardiac K+ channels.
1998,
Pubmed
Rusinova,
Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.
2011,
Pubmed
Rusinova,
A general mechanism for drug promiscuity: Studies with amiodarone and other antiarrhythmics.
2015,
Pubmed
Sack,
A gastropod toxin selectively slows early transitions in the Shaker K channel's activation pathway.
2004,
Pubmed
,
Xenbase
Sack,
Binding of a gating modifier toxin induces intersubunit cooperativity early in the Shaker K channel's activation pathway.
2006,
Pubmed
,
Xenbase
Sheetz,
Biological membranes as bilayer couples. A molecular mechanism of drug-erythrocyte interactions.
1974,
Pubmed
Sheetz,
Equilibrium and kinetic effects of drugs on the shapes of human erythrocytes.
1976,
Pubmed
Showalter,
Tyrosine kinase inhibitors. 6. Structure-activity relationships among N- and 3-substituted 2,2'-diselenobis(1H-indoles) for inhibition of protein tyrosine kinases and comparative in vitro and in vivo studies against selected sulfur congeners.
1997,
Pubmed
Sorota,
Characterization of a hERG screen using the IonWorks HT: comparison to a hERG rubidium efflux screen.
2005,
Pubmed
Spector,
Membrane lipid composition and cellular function.
1985,
Pubmed
Suchyna,
Bilayer-dependent inhibition of mechanosensitive channels by neuroactive peptide enantiomers.
2004,
Pubmed
Søgaard,
GABA(A) receptor function is regulated by lipid bilayer elasticity.
2006,
Pubmed
Tilley,
Chemoselective tarantula toxins report voltage activation of wild-type ion channels in live cells.
2014,
Pubmed
Walpole,
The discovery of capsazepine, the first competitive antagonist of the sensory neuron excitants capsaicin and resiniferatoxin.
1994,
Pubmed
Wells,
Kv1.4 subunit expression is decreased in neurons of painful human pulp.
2007,
Pubmed
Wulff,
Voltage-gated potassium channels as therapeutic targets.
2009,
Pubmed